Hospital Universitario Torrecardenas — Clinical Trial Site

50 Registered trials

18 Currently recruiting

Organisation

Hospital Universitario Torrecardenas

Location

Almeria, Spain

Identifier

ORG-100043220

Address

Calle Paraje Torrecardenas S/n, 04009, Spain

Departments

#3467: Cardiología
3100: Cardiología
3186:Nefrología
Cardiology
Cardiology department
Cirugía
Coloproctología
Digestive
Digestivo
Endocrinology
Endocrinology and metabolism
Gastroenterology
Hematología
Hepatology Department
Hepatology Unit
infectious diseases
Internal Medicine
Internal medicine- Infectious Disease Department
Nefrologia
Nefrology
Nephrology
Neumologia
Neumology
Neurología
Neurology
Neuropediatrics
Oncology
Pediatrics
Peritoneal Oncological Surgery (carcinomatois)-Hepato-Bilio-Biliary-Pancreatic Surgery
Servicio de Angiología y Cirugía vascular
Servicio de Cardiologia
Servicio de Ginecología y Obstetricia
Servicio de Medicina Interna
Servicio de Nefrología
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Vascular Surgery

Clinical trials at this site (50)

Search interface

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients with IgAN Ended

2025-521519-37-00 IgA Nephropathy (IgAN); Berger Disease; Renal and Urina 4 2025-10-10
A study to check the effect of satralizumab in children and adolescents living with Duchenne muscular dystrophy, to check if it is safe and … Ended

2024-512383-65-00 Duchenne Muscular Dystrophy (DMD) 4 2024-09-26
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended

2023-508630-34-00 Overweight 5 2024-05-28
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Uncomplicated bacteremia caused by E. faecalis or E. fa 6 2024-04-29
Study to evaluate reduced antiplatelet therapy after angiolite stent implantation in patients with coronary artery disease Ended

2023-507015-35-00 Coronary Artery Disease 5 2023-10-06
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1) Ended

2022-502839-19-00 Obesity 5 2023-09-14
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection Ended

2022-501901-10-00 Chronic Hepatitis D Infection 6 2023-02-06
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23
Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended

2023-504597-37-00 Focal segmental glomerulosclerosis 5 2022-03-25
A clinical study to assess the efficacy and safety of lanifibranor followed by an active treatment extension in adult patients with non-cirr… Ended

2023-508248-23-00 Non-alcoholic steatohepatitis (NASH) 5 2021-11-26
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Spontaneous Coronary Artery Dissection. 6 2021-09-28
A clinical trial to evaluate the safety and effectiveness of MGL-3196 (resmetirom) in patients with Non-Alcoholic Steatohepatitis (NASH) and… Ended

2024-510626-89-00 Non-Alcoholic Steatohepatitis (NASH) 5 2019-11-18
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Infections due to Enterobacteriaceae 5 2024-05-21
A study to learn if atrasentan is safe and works in people with IgA nephropathy who are taking an SGLT2i Ended

2023-503828-13-00 Nephrology 4 2023-12-12
A study to evaluate the efficacy, safety, participant choice and preference of an oral once-daily regimen or a long-acting injectable regim… Ended

2023-503893-19-00 HIV-1 infection 5 2023-12-06
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Acute vulvovaginal candidiasis 4 2023-09-18
A Study of LY3437943 in Participants with Type 2 Diabetes Mellitus who have Obesity or Overweight (TRIUMPH-2) Ended

2023-503658-11-00 Type 2 Diabetes 5 2023-08-31
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28